<DOC>
	<DOCNO>NCT00891436</DOCNO>
	<brief_summary>Rationale objective : Fluticasone furoate nasal spray ( Veramyst ) show improve ocular symptom use treatment seasonal allergic rhinitis ragweed pollen season . Although publish report intranasal corticosteroid show effectively treat ocular symptom , mechanism delineate . Furthermore , tear patient allergic conjunctivitis know increased concentration cytokine allergic mediator . The objective study determine positive effect Veramyst nasal spray ocular symptom via inhibition allergic mediator eye . The investigator conduct double blind placebo control trial determine Veramyst nasal spray decrease amount allergic mediator tear subject randomize Veramyst nasal spray versus placebo . The investigator also compare subject ' symptom amount allergic mediator detect tear .</brief_summary>
	<brief_title>Study Effect Fluticasone Furoate Nasal Spray Spring Allergy Eye Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>documented history allergic rhinitis conjunctivitis due tree pollen / grass pollen two allergy season positive skin prick test tree / grass glaucoma cataract acute chronic sinusitis asthma chronic obstructive pulmonary disease physical nasal obstruction pregnant breastfeed viral bacterial infection within 2 week study commencement receive allergen immunotherapy use inhaled corticosteroid within 14 day prior study use systemic corticosteroid within 30 day study travel outside geographic area 2 week study period use contact lens study period use artificial tear study period use eyewash irrigation study period use lubricant study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>